Boston Scientific Corp. vs. OraSure Technologies Inc
Boston Scientific Corp. (BSX) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| BSX | OSUR | |
|---|---|---|
| Market Cap | $63.65 billion | $245.53 million |
| Revenue (TTM) | $21.00 billion | $112.41 million |
| Net Income (TTM) | $3.67 billion | $-49,126,000 |
BSX leads on 3 of 3 size & scale factors.
Valuation
| BSX | OSUR | |
|---|---|---|
| P/E Ratio | 17.78 | — |
| Price / Book | 2.53 | 0.77 |
| Price / Sales | 3.03 | 2.18 |
OSUR leads on 2 of 2 valuation factors.
Profitability
| BSX | OSUR | |
|---|---|---|
| Net Margin | 17.47% | -43.70% |
| Return on Equity | 14.58% | -15.46% |
BSX leads on 2 of 2 profitability factors.
Risk & Sentiment
| BSX | OSUR | |
|---|---|---|
| Short Interest | 0.72% | 2.71% |
BSX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, OSUR overview, OSUR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.